MENU
CLYM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Climb Bio (CLYM) Earnings Date & Reports

Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases... Show more

A.I. Advisor
published Earnings

CLYM is expected to report earnings to fall 51.61% to -15 cents per share on August 19

Climb Bio CLYM Stock Earnings Reports
Q2'25
Est.
$-0.15
Q1'25
Missed
by $0.16
The last earnings report on May 14 showed earnings per share of -31 cents, missing the estimate of -15 cents. With 1.01M shares outstanding, the current market capitalization sits at 93.93M.
View a ticker or compare two or three
CLYM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details